Novartis
Basel, Switzerland-based Novartis is one of the largest pharmaceutical companies in the world. The company develops and produces prescription drugs, over-the-counter medications, vaccines and diagnostics.
Date: June 18, 2015
Location: Novartis Institutes for BioMedical Research, Boston
Executives in attendance:
CEO: Yes
CFO: Yes
Head of IR: Yes
Division Managers: Yes
Who may attend: Money managers and sell-side analysts welcome
Number of attendees permitted: 100
Access: Invitation only
Registration required? Yes
Simultaneous webcast? No, but listen-in option planned
Composition of event:
Discussion of company’s financial performance/projections? Yes, if it comes up in the discussions
Overview of strategic outlook? Yes, if it comes up in the discussions
Tours of company facilities? No
Opportunities for Q&A with executives? Yes
Opportunities for one-on-one or small group meetings with key execs? Yes
What readers of Institutional Investor should know about your event:
Investors and analysts will have the opportunity to meet senior leaders from Novartis in breakout sessions, to discuss in an open, informal style in small groups.
For more information contact:
Novartis Investor Relations
Investor.relations@novartis.com
+41-61-324-7944
